Abstract:The National Bone Health Alliance (NBHA) recommends standardized sample handling and patient preparation for C-terminal telopeptide of type I collagen (CTX-I) and N-terminal propeptide of type I procollagen (PINP) measurements to reduce pre-analytical variability. Controllable and uncontrollable patient-related factors are reviewed to facilitate interpretation and minimize pre-analytical variability.IntroductionThe IOF and the International Federation of Clinical Chemistry (IFCC) Bone Marker Standards Working Group have identified PINP and CTX-I in blood to be the reference markers of bone turnover for the fracture risk prediction and monitoring of osteoporosis treatment. Although used in clinical research for many years, bone turnover markers (BTM) have not been widely adopted in clinical practice primarily due to their poor within-subject and between-lab reproducibility. The NBHA Bone Turnover Marker Project team aim to reduce pre-analytical variability of CTX-I and PINP measurements through standardized sample handling and patient preparation.MethodsRecommendations for sample handling and patient preparations were made based on review of available publications and pragmatic considerations to reduce pre-analytical variability. Controllable and un-controllable patient-related factors were reviewed to facilitate interpretation and sample collection.ResultsSamples for CTX-I must be collected consistently in the morning hours in the fasted state. EDTA plasma is preferred for CTX-I for its greater sample stability. Sample collection conditions for PINP are less critical as PINP has minimal circadian variability and is not affected by food intake. Sample stability limits should be observed. The uncontrollable aspects (age, sex, pregnancy, immobility, recent fracture, co-morbidities, anti-osteoporotic drugs, other medications) should be considered in BTM interpretation.ConclusionAdopting standardized sample handling and patient preparation procedures will significantly reduce controllable pre-analytical variability. The successful adoption of such recommendations necessitates the close collaboration of various stakeholders at the global stage, including the laboratories, the medical community, the reagent manufacturers and the regulatory agencies.

A-112 Reference Intervals for Serum Concentrations of N-Terminal Propeptide of Type-I Procollagen (PINP) for Greek Adult Population

A-050 Reference Intervals for Plasma Concentrations of C-Terminal Telopeptide of Type-I Collagen (CTX) for Greek Adult Population

Reference Intervals For Plasma Pro-Gastrin Releasing Peptide (Progrp) Levels In Healthy Adults Of Chinese Han Ethnicity

Bone turnover markers in Spanish adult men The Camargo Cohort Study

Serum bone turnover markers reference intervals establishment in population of Shanghai

Reference Intervals of Β‐c‐terminal Telopeptide of Type I Collagen, Procollagen Type I N‐terminal Propeptide and Osteocalcin for Very Elderly Chinese Men

Bone turnover markers in Spanish postmenopausal women: the Camargo cohort study

SERUM C-C MOTIF LIGAND 11/EOTAXIN-1 MAY SERVE AS A CANDIDATE BIOMARKER FOR POSTMENOPAUSAL OSTEOPOROSIS

Diagnosis value of bone metabolic markers in primary osteoporosis

Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards

[Development and evaluation of a chemiluminescence immunoassay for type Ⅰ procollagen N-terminal peptide]

Serum Procollagen Type I N-Terminal Propeptide and Osteocalcin Levels in Korean Children and Adolescents

Potential of biomarkers during pharmacological therapy setting for postmenopausal osteoporosis: a systematic review

The Role of procollagen type 1 amino-terminal propertied (P1NP) Cytochrome P450 (CYPs) and Osteoprotegerin (OPG) as Potential Bone function markers in Prostate Cancer Bone Metastasis

PoCOsteo: generic novel platform for bone turnover marker measurement & monitoring

Type I collagen markers in cord serum of appropriate vs. small for gestational age infants born during the second half of pregnancy

Independent factors associated with serum N-terminal propeptide of type 1 procollagen in men of advanced age

[Correlation Between Follicle-Stimulating Hormone and Total Procollagen I N-terminal Propeptide in Perimenopausal Women].

Biomarkers as therapy monitoring for postmenopausal osteoporosis: a systematic review

Exploring the Relationship of Bone Turnover Markers and Bone Mineral Density in Community-Dwelling Postmenopausal Women